CPRX.D

CATALYST PHARMACEUTICALS, INC.

Healthcare · Biotechnology

$130.40 sample

+1.49 (+1.16%) 1D

Market cap

$165.7B

Price as of

2026-10-24

Latest filing

8-K · 2026-10-02

Alerts

8

Price$130.40 +9.74% 3M daily closessample

130.46118.83

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 20INSInsider sell: EVP, Operations
Oct 09INSInsider sell: Chief Executive Officer
Oct 02SECForm 144 filed
Sep 28INSInsider sell: General Counsel
Sep 22INSInsider sell: General Counsel
Sep 16INSInsider sell: 10% owner
Sep 09SEC8-K filed: material event
Sep 01SEC10-Q filed

Sign up to see the real CPRX.D record →

Company facts

SEC EDGAR registration

Name: CATALYST PHARMACEUTICALS, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +16sample, -100 to +100
Reporting currency: USD

Who is positioning in CPRX.D

sample

Insiders: 6 insider transactions over 90 days, net selling, $676.0M
Congress: No member trades over 90 days
Institutions · 13F: 15 funds hold $3.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$8.9B +16.2% y/y

Q4 2024Q3 2026

Inventory$5.5B +13.8% y/y

Q4 2024Q3 2026

Accounts receivable$4.0B +9.0% y/y

Q4 2024Q3 2026

Total debt$10.5B +7.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $49.0B -9.9% 3M
Sample peer B: $155.8B -9.8% 3M
Sample peer C: $30.4B +9.5% 3M
Sample peer D: $118.9B +0.5% 3M
Sample peer E: $126.6B +2.6% 3M